| |
| Randomised controlled trial to determine the clinical and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care. The THREAD (THREshold for AntiDepressant response) study |
| Kendrick T, Chatwin J, Dowrick C, Tylee A, Morriss R, Peveler R, Leese M, McCrone P, Harris T, Moore M, Byng R, Brown G, Barthel S, Mander H, Ring A, Kelly V, Wallace V, Gabbay M, Craig T, Mann A |
|
|
| |
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Kendrick T, Chatwin J, Dowrick C, Tylee A, Morriss R, Peveler R, Leese M, McCrone P, Harris T, Moore M, Byng R, Brown G, Barthel S, Mander H, Ring A, Kelly V, Wallace V, Gabbay M, Craig T, Mann A. Randomised controlled trial to determine the clinical and cost-effectiveness of selective serotonin reuptake inhibitors plus supportive care, versus supportive care alone, for mild to moderate depression with somatic symptoms in primary care. The THREAD (THREshold for AntiDepressant response) study. Health Technology Assessment 2009; 13(22): 1-182 Indexing Status Subject indexing assigned by NLM MeSH Adolescent; Adult; Aged; Comorbidity; Cost-Benefit Analysis; Depression /drug therapy /physiopathology /therapy; Female; Fluoxetine /economics /therapeutic use; Great Britain; Humans; Male; Middle Aged; Outcome Assessment (Health Care); Primary Health Care; Psychotherapy; Serotonin Uptake Inhibitors /economics /therapeutic use; Severity of Illness Index; Somatoform Disorders /drug therapy /psychology /therapy; Young Adult AccessionNumber 22009102864 Date bibliographic record published 09/09/2009 |
| |
|
|
